73
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Promoting vascular healing using nanofibrous ticagrelor-eluting stents

, , , , , , , , , , , , & show all
Pages 6039-6048 | Published online: 05 Oct 2018

References

  • GouëfficYPotter-PerigoSChanCKSirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECMAtherosclerosis20071951233017174314
  • ParkJHaHAhnHJSirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cellsTransplant Proc20053783459346216298629
  • JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol200648119320216814667
  • LohJPTorgusonRPendyalaLKImpact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stentsAm J Cardiol2014113121968197624767975
  • BrodieBPokharelYGargAPredictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarctionJACC Cardiovasc Interv20125101043105123078734
  • WilsonGJNakazawaGSchwartzRSComparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteriesCirculation2009120214114919564562
  • HustedSvan GiezenJJTicagrelor: the first reversibly binding oral P2Y12 receptor antagonistCardiovasc Ther200927425927419604248
  • SürerSToktasFAyDEffect of the P2Y12 antagonist ticagrelor on neointimal hyperplasia in a rabbit carotid anastomosis modelInteract Cardiovasc Thorac Surg201419219820424876217
  • TorngrenKOhmanJSalmiHLarssonJErlingeDTicagrelor improves peripheral arterial function in patients with a previous acute coronary syndromeCardiology2013124425225823594617
  • PatilSBJackmanLEFrancisSEJudgeHMNylanderSStoreyRFTicagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointimaArterioscler Thromb Vasc Biol201030122385239121071697
  • OhMLeeCWLeeHSSimilar impact of clopidogrel or ticagrelor on carotid atherosclerotic plaque inflammationClin Cardiol2016391164665227459273
  • TengROliverSHayesMAButlerKAbsorptionBKAbsorption, distribution, metabolism, and excretion of ticagrelor in healthy subjectsDrug Metab Dispos20103891514152120551239
  • BeckerRCBassandJPBudajABleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialEur Heart J201132232933294422090660
  • LuLPeterSJLymanMDIn vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foamsBiomaterials200021181837184510919687
  • KumbarSGNukavarapuSPJamesRNairLSLaurencinCTPolyEElectrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineeringBiomaterials200829304100410718639927
  • AliSADohertyPJWilliamsDFMechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid)J Biomed Mater Res19932711140914188263003
  • WesselyRNew drug-eluting stent conceptsNat Rev Cardiol20107419420320195268
  • ByrneRAKastratiAKufnerSRandomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) TrialEur Heart J200930202441244919720642
  • WindeckerSSerruysPWWandelSBiolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialLancet200837296441163117318765162
  • SerruysPWRegarECarterAJRapamycin eluting stent: the onset of a new era in interventional cardiologyHeart200287430530711906992
  • TeoWERamakrishnaSA review on electrospinning design and nanofibre assembliesNanotechnology20061714R89R10619661572
  • DuttOAshtonHPVC roofing membranes: Factors affecting tensile testsOttawa, CanadaNational Research Council Canada1985
  • LeeCHChangSHChenWJAugmentation of diabetic wound healing and enhancement of collagen content using nanofibrous glucophage-loaded collagen/PLGA scaffold membranesJ Colloid Interface Sci2015439889725463179
  • KalyaniLLakshmana RaoAA validated stability-indicating HPLC method for determination of ticagrelor in bulk and its formulationInt J Pharm20133634642
  • KukrejaNOnumaYDaemenJSerruysPWThe future of drug-eluting stentsPharmacol Res200857317118018339557
  • HedenqvistPAnaesthesia and analgesia for surgery in rabbits and rats: a comparison of the effects of different compoundsStockholm, SwedenKarolinska Institute, Department of Physiology and Pharmacology2008
  • PhinikaridouAHuaNPhamTHamiltonJARegions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging studyCirc Cardiovasc Imaging20136230231023357244
  • MasuoOTeradaTWalkerGStudy of the patency of small arterial branches after stent placement with an experimental in vivo modelAJNR Am J Neuroradiol200223470671011950673
  • TanakaHSukhovaGKSwansonSJSustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injuryCirculation1993884 Pt 1178818037691431
  • TanakaHSukhovaGSchwartzDLibbyPProliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factorArterioscler Thromb Vasc Biol199616112188548411
  • LeeC-HChangS-HLinY-HAcceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stentsBiomaterials201435154417442724582553
  • DroletMCPlanteEBattistiniBCouetJArsenaultMEarly endothelial dysfunction in cholesterol-fed rabbits: a non-invasive in vivo ultrasound studyCardiovasc Ultrasound200421015268763
  • NakazawaGGranadaJFAlviarCLAnti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelializationJACC Cardiovasc Interv201031687520129572
  • KornowskiRHongMKTioFOBramwellOWuHLeonMBIn-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasiaJ Am Coll Cardiol19983112242309426044
  • SchwartzRSHuberKCMurphyJGRestenosis and the proportional neointimal response to coronary artery injury: results in a porcine modelJ Am Coll Cardiol19921922672741732351
  • LacoFGrantMHBlackRACollagen-nanofiber hydrogel composites promote contact guidance of human lymphatic microvascular endothelial cells and directed capillary tube formationJ Biomed Mater Res A201310161787179923197422
  • FarnsworthRHAchenMGStackerSALymphatic endothelium: an important interactive surface for malignant cellsPulm Pharmacol Ther2006191516016286238
  • ArimaYIwataHEffect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayersBiomaterials200728203074308217428532
  • LeeSJKhangGLeeYMLeeHBInteraction of human chondrocytes and NIH/3T3 fibroblasts on chloric acid-treated biodegradable polymer surfacesJ Biomater Sci Polym Ed200213219721212022750
  • MalkinAYArinsteinAKulichikhinVGPolymer extension flows and instabilitiesProg Polym Sci2014395959978
  • MakadiaHKSiegelSJPoly Lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers2011331377139722577513
  • RamchandaniMRobinsonDIn vitro and in vivo release of ciprofloxacin from PLGA 50:50 implantsJ Control Release19985421671759724903
  • BonelloLFrereCCointeSTicagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: a prospective randomized studyInt J Cardiol201518750250725846661
  • DavìGPatronoCPlatelet activation and atherothrombosisN Engl J Med2007357242482249418077812
  • SopovaKTatsidouPStellosKPlatelets and platelet interaction with progenitor cells in vascular homeostasis and inflammationCurr Vasc Pharmacol201210555556222338570
  • Vieira-de-AbreuACampbellRAWeyrichASZimmermanGAPlatelets: versatile effector cells in hemostasis, inflammation, and the immune continuumSemin Immunopathol201234153021818701
  • OwensGKKumarMSWamhoffBRMolecular regulation of vascular smooth muscle cell differentiation in development and diseasePhysiol Rev200484376780115269336
  • LiXZhangXLeathersRNotch3 signaling promotes the development of pulmonary arterial hypertensionNat Med200915111289129719855400
  • StegPGHarringtonRAEmanuelssonHStent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialCirculation2013128101055106523900047
  • KimHKJeongMHLimKSEffects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis modelInt J Cardiol201724032633128487152
  • PreuschMRRusnakJStaudacherKTicagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosisDrug Des Devel Ther20161026912699
  • TribbleDLBarcellos-HoffMHChuBMGongELIonizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processesArterioscler Thromb Vasc Biol19991961387139210364068
  • LiuJQZelkoINFolzRJReoxygenation-induced constriction in murine coronary arteries: the role of endothelial NADPH oxidase (gp91phox) and intracellular superoxideJ Biol Chem200427923244932449715070892
  • DidionSPRyanMJDidionLAFeganPESigmundCDFaraciFMIncreased superoxide and vascular dysfunction in CuZnSOD-deficient miceCirc Res2002911093894412433839
  • StockerRKeaneyJFRole of oxidative modifications in atherosclerosisPhysiol Rev20048441381147815383655
  • MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med2003349141315132314523139
  • WesselyRSchömigAKastratiASirolimus and paclitaxel on polymer-based drug-eluting stents: similar but differentJ Am Coll Cardiol200647470871416487832
  • ChangSHLeeCHYehYHPropylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injuryInt J Nanomedicine20181313
  • LeeCHLinYHChangSHLocal sustained delivery of acetyl-salicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded arteryInt J Nanomedicine2014931124421640
  • LeeCHChangSHLinYHAcceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stentsBiomaterials201435154417442724582553
  • RäberLJüniPNüeschELong-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularizationJ Am Coll Cardiol201157212143215121596229
  • JensenLOThayssenPChristiansenEHSafety and efficacy of everolimus- versus sirolimus-eluting stents: 5-year results from SORT OUT IVJ Am Coll Cardiol201667775176226892409